Enractin Neo 90mg/48mg/100mg Tablet is a combination pharmaceutical formulation containing Bromelain 90mg, Trypsin 48mg, and Rutoside 100mg, designed to provide anti-inflammatory, proteolytic, and vascular protective effects. Bromelain, a proteolytic enzyme derived from pineapple stems, facilitates the breakdown of proteins, thereby reducing inflammation and edema in acute and chronic inflammatory conditions. Trypsin, another proteolytic enzyme, complements bromelain by enhancing fibrinolytic activity and promoting the resolution of inflammation through protease-mediated mechanisms. Rutoside, a bioflavonoid, exerts antioxidant properties and strengthens capillary walls, improving microcirculation and reducing capillary permeability. This synergistic combination is indicated for the management of inflammatory disorders, postoperative and post-traumatic swelling, hematoma resolution, and venous insufficiency. Enractin Neo is particularly effective in reducing pain, edema, and bruising associated with musculoskeletal injuries and surgical interventions. The tablet formulation ensures convenient oral administration with optimal bioavailability. It is recommended to be used under medical supervision, considering contraindications such as hypersensitivity to any component, bleeding disorders, or concurrent anticoagulant therapy. Adverse effects are generally mild and infrequent but may include gastrointestinal discomfort or allergic reactions. Enractin Neo represents a targeted therapeutic option for enhancing recovery and reducing inflammation in various clinical scenarios.